vs
Assertio Holdings, Inc.（ASRT）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.2倍（$13.5M vs $11.1M），NexPoint Real Estate Finance, Inc.同比增速更快（-48.8% vs -57.9%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
ASRT vs NREF — 直观对比
营收规模更大
ASRT
是对方的1.2倍
$11.1M
营收增速更快
NREF
高出9.1%
-57.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $11.1M |
| 净利润 | — | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | — |
| 净利率 | — | 216.6% |
| 营收同比 | -57.9% | -48.8% |
| 净利润同比 | — | 58.7% |
| 每股收益（稀释后） | $-4.54 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTNREF
| Q4 25 | $13.5M | $11.1M | ||
| Q3 25 | $49.5M | $12.5M | ||
| Q2 25 | $29.2M | $12.1M | ||
| Q1 25 | $26.5M | $11.5M | ||
| Q4 24 | $32.2M | $21.7M | ||
| Q3 24 | $29.2M | $12.5M | ||
| Q2 24 | $31.1M | $6.7M | ||
| Q1 24 | $32.4M | $-12.8M |
净利润ASRTNREF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $11.4M | $50.9M | ||
| Q2 25 | $-16.4M | $22.3M | ||
| Q1 25 | $-13.5M | $26.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $-2.9M | $23.3M | ||
| Q2 24 | $-3.7M | $12.1M | ||
| Q1 24 | $-4.5M | $-14.6M |
营业利润率ASRTNREF
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | -27.5% | — | ||
| Q1 25 | -50.0% | — | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -13.4% | — |
净利率ASRTNREF
| Q4 25 | — | 216.6% | ||
| Q3 25 | 23.1% | 407.0% | ||
| Q2 25 | -56.0% | 184.5% | ||
| Q1 25 | -51.1% | 225.6% | ||
| Q4 24 | — | 69.9% | ||
| Q3 24 | -10.0% | 186.4% | ||
| Q2 24 | -11.8% | 179.7% | ||
| Q1 24 | -13.9% | 114.3% |
每股收益（稀释后）ASRTNREF
| Q4 25 | $-4.54 | $0.47 | ||
| Q3 25 | $0.11 | $1.14 | ||
| Q2 25 | $-0.17 | $0.54 | ||
| Q1 25 | $-0.14 | $0.70 | ||
| Q4 24 | $-3.28 | $0.71 | ||
| Q3 24 | $-0.03 | $0.74 | ||
| Q2 24 | $-0.04 | $0.40 | ||
| Q1 24 | $-0.05 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $94.0M | $388.0M |
| 总资产 | $267.0M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资ASRTNREF
| Q4 25 | $63.4M | $31.1M | ||
| Q3 25 | $93.4M | $17.9M | ||
| Q2 25 | $98.2M | $9.1M | ||
| Q1 25 | $87.3M | $19.2M | ||
| Q4 24 | $100.1M | $3.9M | ||
| Q3 24 | $88.6M | $34.7M | ||
| Q2 24 | $88.4M | $4.3M | ||
| Q1 24 | $80.7M | $13.5M |
总债务ASRTNREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | $38.6M | $843.3M |
股东权益ASRTNREF
| Q4 25 | $94.0M | $388.0M | ||
| Q3 25 | $105.8M | $375.4M | ||
| Q2 25 | $93.3M | $348.2M | ||
| Q1 25 | $108.5M | $343.7M | ||
| Q4 24 | $121.1M | $336.5M | ||
| Q3 24 | $130.5M | $335.8M | ||
| Q2 24 | $132.2M | $327.5M | ||
| Q1 24 | $134.5M | $327.1M |
总资产ASRTNREF
| Q4 25 | $267.0M | $5.3B | ||
| Q3 25 | $319.8M | $5.3B | ||
| Q2 25 | $273.8M | $5.4B | ||
| Q1 25 | $286.4M | $5.4B | ||
| Q4 24 | $284.7M | $5.4B | ||
| Q3 24 | $276.0M | $5.7B | ||
| Q2 24 | $279.4M | $6.6B | ||
| Q1 24 | $282.0M | $7.1B |
负债/权益比ASRTNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | 0.29× | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTNREF
| Q4 25 | $-30.0M | $-4.5M | ||
| Q3 25 | $-4.8M | $8.1M | ||
| Q2 25 | $19.1M | $3.3M | ||
| Q1 25 | $-12.5M | $16.0M | ||
| Q4 24 | $11.5M | $4.4M | ||
| Q3 24 | $-35.0K | $14.7M | ||
| Q2 24 | $7.4M | $-7.5M | ||
| Q1 24 | $7.5M | $17.7M |
资本支出强度ASRTNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | -0.42× | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
NREF
暂无分部数据
